Ali Mohamed
Company: Immatics
Job title: SVP of CMC
Seminars:
Developing Next-Generation Allogeneic Therapies for Solid Tumors Based on Gamma Delta T cells 2:30 pm
Discussing characteristics of gamma delta T cells as source for an allogeneic cell therapy approach Redirecting gamma delta T cells with TCRs against peptide-HLA targets to combat solid tumors Exploring next-gen strategies to potentiate anti-tumor activityRead more
day: Day Two
Revolutionizing Data Management & Process Integration 11:15 am
day: Day 2: Supply/Storage
Driving Scalable Manufacturing & Optimizing Characterization for Successful Commercialisation of Allogenic Therapies 11:15 am
day: Day 2: Manufacturing & CMC